Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company.
Several equities research analysts recently weighed in on STVN shares. CJS Securities started coverage on shares of Stevanato Group in a research note on Tuesday, September 19th. They set an “outperform” rating and a $36.00 target price on the stock. Wells Fargo & Company boosted their price target on shares of Stevanato Group from $30.00 to $35.00 and gave the stock an “overweight” rating in a report on Monday, July 31st. KeyCorp boosted their price target on shares of Stevanato Group from $35.00 to $37.00 and gave the stock an “overweight” rating in a report on Wednesday, August 30th. Morgan Stanley lowered their price target on shares of Stevanato Group from $34.00 to $30.00 and set an “equal weight” rating for the company in a report on Wednesday, November 1st. Finally, Stephens started coverage on shares of Stevanato Group in a report on Monday, September 25th. They set an “overweight” rating and a $33.00 price target for the company.
Institutional Inflows and Outflows
Stevanato Group Price Performance
Stevanato Group stock opened at €27.92 ($30.68) on Tuesday. The company’s 50 day simple moving average is €29.62 and its 200-day simple moving average is €30.33. The company has a market capitalization of $8.25 billion, a price-to-earnings ratio of 47.32, a price-to-earnings-growth ratio of 4.08 and a beta of 0.87. Stevanato Group has a 1 year low of €14.02 ($15.41) and a 1 year high of €36.30 ($39.89). The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.91 and a current ratio of 1.41.
Stevanato Group (NYSE:STVN – Get Free Report) last announced its earnings results on Tuesday, October 31st. The company reported €0.16 ($0.18) earnings per share for the quarter, hitting the consensus estimate of €0.16 ($0.18). Stevanato Group had a net margin of 14.05% and a return on equity of 14.87%. The firm had revenue of €295.39 million for the quarter, compared to the consensus estimate of €305.22 million. As a group, equities research analysts expect that Stevanato Group will post 0.61 earnings per share for the current year.
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.
- Five stocks we like better than Stevanato Group
- The Role Economic Reports Play in a Successful Investment Strategy
- The most upgraded stocks in November have two things in common
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Monday.com rocked earnings like it’s the weekend
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Plan to own one retailer? Make it this one
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.